Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript
Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Ikarian Capital Neil Shahrestani | 120,031 | $52,070 | 0.01% | |
2. | Citadel Investment Group Ken Griffin | 36,018 | $15,625 | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.69 | 14,000 | $9,703.40 | 250,000 | 2023-06-07 | Filing | |
$0.63 | 26,000 | $16,452.80 | 236,000 | 2023-06-06 | Filing | |
$1.04 | 25,000 | $26,075.00 | 210,000 | 2023-02-10 | Filing | |
$0.94 | 25,000 | $23,512.50 | 185,000 | 2023-02-02 | Filing | |
$0.87 | 25,000 | $21,825.00 | 160,000 | 2023-01-25 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.65 | 69,161 | $44,954.65 | 165,332 | 2019-04-03 | Filing | |
$0.65 | 26,080 | $16,952.00 | 62,342 | 2019-04-03 | Filing | |
$0.66 | 9,909 | $6,539.94 | 234,493 | 2019-04-02 | Filing | |
$0.66 | 3,737 | $2,466.42 | 88,422 | 2019-04-02 | Filing | |
$0.67 | 30,265 | $20,277.55 | 244,402 | 2019-04-01 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 35,601 | $15,444 | 0% | |
2. | 18,601 | $8,069 | 0% | |
3. | 17,818 | $7,729 | 0% | |
4. | 17,187 | $7,456 | 0% | |
5. | 7,568 | $3,283 | 0% |